Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypomania, Amphetamine, and Sweets Preference
NCT03810703Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Feb 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dextroamphetamine (3 arms), sponsored by University of Chicago. Primary endpoint: Drug Effects Questionnaire Score at 4 weeks. Started Feb 2017; status: completed.
02
Drugs
dextroamphetamine
Beyond the preview
Go deeper on NCT03810703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03810703.